RRAD and lung cancer: These results suggest that RRAD is an important mediator for p53 to antagonize the stimulating effect of hypoxia on glycolysis; in response to hypoxia, p53 activation induces RRAD expression, leading to the down-regulation of glycolysis in lung cancer cells.